Selected research
Industry Research
Non-opioid Analgesic Patch Industry Research Report 2026
Market perspective
The global Non-opioid Analgesic Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Non-opioid Analgesic Patch market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Non-opioid Analgesic Patch market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Non-opioid Analgesic Patch market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Non-opioid Analgesic Patch include Acorda Therapeutics, Inc, Allergan, Endo International plc, Hisamitsu Pharmaceutical Co.,Inc, IBSA Institut Biochimque SA, Teh Seng Pharmaceutical Mfg, Teikoku Seiyaku Co., Ltd., GlaxoSmithKline Plc and Pfizer, Inc. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Non-opioid Analgesic Patch market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Non-opioid Analgesic Patch.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-opioid Analgesic Patch Market by Company
Acorda Therapeutics, Inc
Allergan
Endo International plc
Hisamitsu Pharmaceutical Co.,Inc
IBSA Institut Biochimque SA
Teh Seng Pharmaceutical Mfg
Teikoku Seiyaku Co., Ltd.
GlaxoSmithKline Plc
Pfizer, Inc.
Mylan N.V.
Non-opioid Analgesic Patch Segment by Type
Capsaicin Patches
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Ketoprofen Patches
Others
Non-opioid Analgesic Patch Segment by Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Non-opioid Analgesic Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Analgesic Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Analgesic Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Analgesic Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Non-opioid Analgesic Patch companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsaicin Patches
- Lidocaine Patches
- Diclofenac Patches
- Methyl Salicylate Patches
- Ketoprofen Patches
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Independent Pharmacies & Drug Stores
Companies covered
- Acorda Therapeutics, Inc
- Allergan
- Endo International plc
- Hisamitsu Pharmaceutical Co.,Inc
- IBSA Institut Biochimque SA
- Teh Seng Pharmaceutical Mfg
- Teikoku Seiyaku Co., Ltd.
- GlaxoSmithKline Plc
- Pfizer, Inc.
- Mylan N.V.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Non-opioid Analgesic Patch by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Capsaicin Patches
- 2.2.3 Lidocaine Patches
- 2.2.4 Diclofenac Patches
- 2.2.5 Methyl Salicylate Patches
- 2.2.6 Ketoprofen Patches
- 2.2.7 Others
- 2.3 Non-opioid Analgesic Patch by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Independent Pharmacies & Drug Stores
- 2.4 Assumptions and Limitations
3 Non-opioid Analgesic Patch Breakdown Data by Type
- 3.1 Global Non-opioid Analgesic Patch Historic Market Size by Type (2021-2026)
- 3.2 Global Non-opioid Analgesic Patch Forecasted Market Size by Type (2027-2032)
4 Non-opioid Analgesic Patch Breakdown Data by Application
- 4.1 Global Non-opioid Analgesic Patch Historic Market Size by Application (2021-2026)
- 4.2 Global Non-opioid Analgesic Patch Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Non-opioid Analgesic Patch Market Perspective (2021-2032)
- 5.2 Global Non-opioid Analgesic Patch Growth Trends by Region
- 5.2.1 Global Non-opioid Analgesic Patch Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Non-opioid Analgesic Patch Historic Market Size by Region (2021-2026)
- 5.2.3 Non-opioid Analgesic Patch Forecasted Market Size by Region (2027-2032)
- 5.3 Non-opioid Analgesic Patch Market Dynamics
- 5.3.1 Non-opioid Analgesic Patch Industry Trends
- 5.3.2 Non-opioid Analgesic Patch Market Drivers
- 5.3.3 Non-opioid Analgesic Patch Market Challenges
- 5.3.4 Non-opioid Analgesic Patch Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Non-opioid Analgesic Patch Players by Revenue
- 6.1.1 Global Top Non-opioid Analgesic Patch Players by Revenue (2021-2026)
- 6.1.2 Global Non-opioid Analgesic Patch Revenue Market Share by Players (2021-2026)
- 6.2 Global Non-opioid Analgesic Patch Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Non-opioid Analgesic Patch Head Office and Area Served
- 6.4 Global Non-opioid Analgesic Patch Players, Product Type & Application
- 6.5 Global Non-opioid Analgesic Patch Manufacturers Established Date
- 6.6 Global Non-opioid Analgesic Patch Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Non-opioid Analgesic Patch Market Size (2021-2032)
- 7.2 North America Non-opioid Analgesic Patch Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Non-opioid Analgesic Patch Market Size by Country (2021-2026)
- 7.4 North America Non-opioid Analgesic Patch Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Non-opioid Analgesic Patch Market Size (2021-2032)
- 8.2 Europe Non-opioid Analgesic Patch Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Non-opioid Analgesic Patch Market Size by Country (2021-2026)
- 8.4 Europe Non-opioid Analgesic Patch Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Non-opioid Analgesic Patch Market Size (2021-2032)
- 9.2 Asia-Pacific Non-opioid Analgesic Patch Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Non-opioid Analgesic Patch Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Non-opioid Analgesic Patch Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Non-opioid Analgesic Patch Market Size (2021-2032)
- 10.2 South America Non-opioid Analgesic Patch Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Non-opioid Analgesic Patch Market Size by Country (2021-2026)
- 10.4 South America Non-opioid Analgesic Patch Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Non-opioid Analgesic Patch Market Size (2021-2032)
- 11.2 Middle East & Africa Non-opioid Analgesic Patch Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Non-opioid Analgesic Patch Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Non-opioid Analgesic Patch Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Acorda Therapeutics, Inc
- 12.1.1 Acorda Therapeutics, Inc Company Information
- 12.1.2 Acorda Therapeutics, Inc Business Overview
- 12.1.3 Acorda Therapeutics, Inc Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.1.4 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Portfolio
- 12.1.5 Acorda Therapeutics, Inc Recent Developments
- 12.2 Allergan
- 12.2.1 Allergan Company Information
- 12.2.2 Allergan Business Overview
- 12.2.3 Allergan Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.2.4 Allergan Non-opioid Analgesic Patch Product Portfolio
- 12.2.5 Allergan Recent Developments
- 12.3 Endo International plc
- 12.3.1 Endo International plc Company Information
- 12.3.2 Endo International plc Business Overview
- 12.3.3 Endo International plc Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.3.4 Endo International plc Non-opioid Analgesic Patch Product Portfolio
- 12.3.5 Endo International plc Recent Developments
- 12.4 Hisamitsu Pharmaceutical Co.,Inc
- 12.4.1 Hisamitsu Pharmaceutical Co.,Inc Company Information
- 12.4.2 Hisamitsu Pharmaceutical Co.,Inc Business Overview
- 12.4.3 Hisamitsu Pharmaceutical Co.,Inc Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.4.4 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Portfolio
- 12.4.5 Hisamitsu Pharmaceutical Co.,Inc Recent Developments
- 12.5 IBSA Institut Biochimque SA
- 12.5.1 IBSA Institut Biochimque SA Company Information
- 12.5.2 IBSA Institut Biochimque SA Business Overview
- 12.5.3 IBSA Institut Biochimque SA Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.5.4 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Portfolio
- 12.5.5 IBSA Institut Biochimque SA Recent Developments
- 12.6 Teh Seng Pharmaceutical Mfg
- 12.6.1 Teh Seng Pharmaceutical Mfg Company Information
- 12.6.2 Teh Seng Pharmaceutical Mfg Business Overview
- 12.6.3 Teh Seng Pharmaceutical Mfg Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.6.4 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolio
- 12.6.5 Teh Seng Pharmaceutical Mfg Recent Developments
- 12.7 Teikoku Seiyaku Co., Ltd.
- 12.7.1 Teikoku Seiyaku Co., Ltd. Company Information
- 12.7.2 Teikoku Seiyaku Co., Ltd. Business Overview
- 12.7.3 Teikoku Seiyaku Co., Ltd. Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.7.4 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Portfolio
- 12.7.5 Teikoku Seiyaku Co., Ltd. Recent Developments
- 12.8 GlaxoSmithKline Plc
- 12.8.1 GlaxoSmithKline Plc Company Information
- 12.8.2 GlaxoSmithKline Plc Business Overview
- 12.8.3 GlaxoSmithKline Plc Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.8.4 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Portfolio
- 12.8.5 GlaxoSmithKline Plc Recent Developments
- 12.9 Pfizer, Inc.
- 12.9.1 Pfizer, Inc. Company Information
- 12.9.2 Pfizer, Inc. Business Overview
- 12.9.3 Pfizer, Inc. Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.9.4 Pfizer, Inc. Non-opioid Analgesic Patch Product Portfolio
- 12.9.5 Pfizer, Inc. Recent Developments
- 12.10 Mylan N.V.
- 12.10.1 Mylan N.V. Company Information
- 12.10.2 Mylan N.V. Business Overview
- 12.10.3 Mylan N.V. Revenue in Non-opioid Analgesic Patch Business (2021-2026)
- 12.10.4 Mylan N.V. Non-opioid Analgesic Patch Product Portfolio
- 12.10.5 Mylan N.V. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst